Evaluation of intravenous immunoglobulin (IVIG) as an agent to lower allosensitization and improve transplantation in highly-sensitized adult ESRD patients: report of the NIH IG02 trial

Publication Type
Journal Article
Year of Publication
2004
Authors
Jordan, SC; Tyan, D; Stablein, D; McIntosh, M; Rose, S; Vo, A; Toyoda, M; Davis, C; Shapiro, R; Adey, D; Milliner, D; Graff, R; Steiner, R; Ciancio, G; Sahney, S; Light, J
Secondary
J Am Soc Nephrol
Pagination
3256-3262
Date Published
2004